Working With Us...

 

Using the IP portfolio: Remember - Cost - Indemnity - Diligence - Benefit


All intellectual property developed by the researchers of the NanoTechnology Center is property of Wake Forest University.  The University seeks to license and develop its IP using a variety of instruments.  University priorities seek to achieve the following aims in its license provisions:


1)  Protection of the University against liability in the use of any product that may be derived from its IP.  Since we are not the manufacturer’s of such products, the University can not warranty implementation.


2)  A cost neutral status for the maintenance of IP protection.  This means that costs associated with patent protection are incurred by the licensee for as long as the license is enforced. Typically ORIGINAL PATENT COSTS are included among the fees.


3)  Diligence.  The University is interested in having products result from its work.  Thus we ask that some provision for determining progress toward that end be enacted in the license.  These provisions may be based on projected market entry, market size and business verticals, development costs and partnerships, etc.  Provisions for retrieval of underutilized IP are negotiated with Wake Forest Innovations (our IP management office).


4)  Benefit to the University.  This usually takes the form of Royalties or minimum payments.  These “benefits” to the University are used exclusively to carry out the mission of the University in teaching and scholarship.  This is done in accordance with our “not for profit” status.


The final arbiter of license events with the Nanotechnology Center is Wake Forest Innovations at Wake Forest University / Wake Forest Health Sciences.  If you are interested in working together with our scientists please contact Dr. David Carroll (carroldl@wfu.edu).

A few of the Nanotechnology Center’s Innovations (there is a little Edison in us all):

                                                

BioMedical


Classification: NanoCancer


  1. 1)Nanoparticle Mediated Hyperthermia Approaches to Cancer using Allotropes of NanoCarbon

Status: Multiple Issued Patents Europe/US/Asia. Animal data available together with numerous publications. 

Description: Carbon Nanotube and their variants injected into, targeted to, or otherwise dispersed into tumors.  When IR is applied from outside the body and penetrates into the tumor volume, the nanotubes provide enhanced heat transduction and cell death (hyperthermia). 

  1. 2)Nanoparticle Hyperthermia coupled with Drug Therapies

Status: Animal data available.

Description: Carbon Nanotubes and other nanoparticles used concurrently with specific chemotherapeutics to enhance drug uptake.  Tissue penetrating IR is used to activate soft-hyperthermia increasing the efficacy of chemo drugs.

  1. 3)Polymer-based nanoparticle mediated Hyperthermia approaches  to Cancer

Status: Cell Culture data available

Description: Novel conducting polymers that are biocompatible and in crystallized nanoparticle form. Using tissue penetrating IR these are activated in a tumor to cause hyperthermia.  The polymeric materials make clearance problems tractable.

  1. 4) NanoEngineered Embolizing Agent

Status: animal data in non-human primates

Description: A novel embolizing agent for use with current RF technology for tumor ablation.

  1. 5)NanoChemical mediated hyperthermia approaches to Cancer

Status: in situ and cell culture data available

Description: a novel set of nanoparticles that drive exothermic reactions in tumorgenic environments coupled with a unique targeting and delivery system.                                                                             


Classification: BioSensors and Bioelectronics


  1. 6)Next Generation of Pressure Sensors for use clinical us “NanoTorr”

Status: Animal data comparing to standard pressure devices used in medicine                                                                                                                                                             

Description: a novel optically based pressure sensor to replace the current clinical catheters.

  1. 7)Clinical Sensing of Strain coupled with RFID “OrthoCorrect”  

Status: Licensed  

Description: A set of RFID based strain sensors which adhere to the skin.                                                                                                                                                       


Power/Green Energy


classification: Solar PV/T


  1. 1)3D architectures for Organic Photovoltaics “FiberCell”

Status: Licensed

Description: a 3D optical architecture for use with organic absorbers.

  1. 2)3D architectures for Inorganic Photovoltaics

Status: Licensed

Description: 3D optical architectures for use with inorganic absorbers

  1. 3)High efficiency PV/T (Solar-Thermal) systems based on Stokes shifting dyes. 

Status: issued with divisionals under examination                                                                                                                                

Description: a novel 3D device design that allows for greater optical and thermal energy capture.  Working demonstrators available.

  1. 4)Organic donor-acceptor morphologies for increased OPV performance

Status: Issued

Description: Morphology Control in bulk heterojunction systems using a variety of means.  Multiple publications available as well as test data.


classification: Lighting


  1. 5)White emitting polymer compositions

Status: Licensed

Description: new and novel polymer compositions for white light emission

  1. 6)High impedance, field activated devices for high efficiency organic light emitters 

Status: Licensed

Description: new and novel device architectures for front surface emission large area panels.

  1. 7)Inorganic, field activated lighting systems based on nanocomposites

Status: Licensed

Description: A novel device architectures that uses inorganic phosphors.

  1. 8)Power generating fabrics based on thermoelectric -piezo electric organic nanofibers. “PowerFelt” 

Status:    contact us

Description: contact us


                                                                                                                           

There are no rules here - we are trying to accomplish something...(Thomas Edison)

August 29, 1918 Thomas Edison along with Ford and Firestone, visited Winston-Salem. (Left) are a few of the image taken on that day.